reliance on sales in China. At present, the Company’s products are well- received in the Philippines but still could not make up for the slowdown in sales in China. The Company is committed to expanding
in China. The Company is committed to expanding further to other potential countries and is in the process of conducting market feasibility studies in certain markets. Apart from that, the Company was
for the slowdown in sales in China. The Company is committed to expanding further to other potential countries and is in the process of conducting market feasibility studies in certain markets. Apart
personal expenses and the depreciation because of the expanding capacity of subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing Director
Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and
operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity
& Administrative expenses increased by Baht 23.54 million or 13.02 % due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 3. Finance costs increased by Baht 13.17
increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling
recorded total sales volume increased 5% YoY, mainly from the retail market increasing by 7% YoY, stemming from the company’s strategy to focus on expanding its customer base, and to actively push the sales
expanding health care service providers including check-up and occupational health for general clients aimed to enhance the Company’s sustainability growth which involves the next step of expanding scope of